Skip header and navigation

Narrow By

   MORE

145 records – page 6 of 8.

Oral irons and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35375
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1469
Available Online
View Pamphlet
Many people with chronic kidney disease (CKD) have anemia (not enough red blood cells or hemoglobin in the blood). Taking oral irons will give you enough iron to make hemoglobin. The pamphlet explains what oral irons are, how to take and store them, and possible side effects.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Alternate Title
Oral irons and CKD
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal insufficiency, chronic - complications
Renal Insufficiency, Chronic - drug therapy
Anemia, Iron-Deficiency - drug therapy
Subjects (LCSH)
Chronic renal failure--Complications
Iron deficiency anemia
Renal pharmacology
Abstract
Many people with chronic kidney disease (CKD) have anemia (not enough red blood cells or hemoglobin in the blood). Taking oral irons will give you enough iron to make hemoglobin. The pamphlet explains what oral irons are, how to take and store them, and possible side effects.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1469
Less detail

Oral Systemic Therapy

https://libcat.nshealth.ca/en/permalink/chpams37366
Nova Scotia Health. Cancer Care Program. [Halifax, NS]: Nova Scotia Cancer Care Program , 2018.
Pamphlet Number
0038
Available Online
View Pamphlet
This pamphlet provides an overview of oral systemic therapy for cancer treatment. Includes how to get and take the treatment, for how long, what tests are needed, and what are the risks and side effects of the treatement.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health. Cancer Care Program
Place of Publication
[Halifax, NS]
Publisher
Nova Scotia Cancer Care Program
Date of Publication
2018
Format
Pamphlet
Language
English
Physical Description
1 electronic document (8 p.) : digital, PDF file
Subjects (MeSH)
Neoplasms - drug therapy
Subjects (LCSH)
Cancer--Chemotherapy
Specialty
Pharmacy
Abstract
This pamphlet provides an overview of oral systemic therapy for cancer treatment. Includes how to get and take the treatment, for how long, what tests are needed, and what are the risks and side effects of the treatement.
Notes
Patient & family guide
Responsibility
prepared by Nova Scotia Cancer Care Program
Pamphlet Number
0038
Less detail

Paliperidone (Invega®) and paliperidone palmitate (Invega Sustenna®, Invega Trinza®

https://libcat.nshealth.ca/en/permalink/chpams36494
Nova Scotia Health Authority. QE II. Pharmacy Services. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1938
Available Online
View Pamphlet
Paliperidone is most often used to treat psychosis or mania. This pamphlet explains how to take paliperidone, what symptoms it will help with, and possible side effects. Rare, serious side effects that require a visit to the Emergency Department are listed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QE II. Pharmacy Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Paliperidone Palmitate - therapeutic use
Psychotic Disorders - drug therapy
Mania - drug therapy
Subjects (LCSH)
Psychoses--Treatment
Mania
Specialty
Medications
Abstract
Paliperidone is most often used to treat psychosis or mania. This pamphlet explains how to take paliperidone, what symptoms it will help with, and possible side effects. Rare, serious side effects that require a visit to the Emergency Department are listed.
Notes
Previous title: Paliperidone (Invega); Paliperidone Palmitate (Invega Sustenna)
Responsibility
Prepared by: Pharmacy Services, QE II
Pamphlet Number
1938
Less detail

Peripheral Neuropathy (also called Nerve Damage)

https://libcat.nshealth.ca/en/permalink/chpams37428
Nova Scotia Health. Cancer Care Program. [Halifax, NS]: Nova Scotia Cancer Care Program , 2019.
Pamphlet Number
1684
Available Online
View Pamphlet
This pamphlets describes the symptoms of peripheral neuropathy (nerve damage) sometimes caused by cancer treatment, and outlines treatment and coping strategies.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health. Cancer Care Program
Place of Publication
[Halifax, NS]
Publisher
Nova Scotia Cancer Care Program
Date of Publication
2019
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Antineoplastic Agents - adverse effects
Drug-Related Side Effects and Adverse Reactions
Peripheral Nervous System Diseases - chemically induced
Subjects (LCSH)
Antineoplastic agents--Side effects
Cancer--Chemotherapy--Complications
Nerves, Peripheral--Effect of drugs on
Specialty
Neurology
Abstract
This pamphlets describes the symptoms of peripheral neuropathy (nerve damage) sometimes caused by cancer treatment, and outlines treatment and coping strategies.
Notes
Patient & family guide
Responsibility
prepared by Nova Scotia Health Authority Cancer Care Program
Pamphlet Number
1684
Less detail

La pilule contraceptive

https://libcat.nshealth.ca/en/permalink/chpams36608
Nova Scotia Health Authority. Nova Scotia Women's Choice Clinic. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
2027
Available Online
View Pamphlet
La pilule contraceptive empêche la grossesse en arrêtant le cycle d’ovulation, en provoquant l’épaississement des sécrétions (mucus) du col de l’utérus et en modifiant la paroi intérieure de l’utérus. Le livret explique le fonctionnement de la pilule, le moment où elle commence son travail, ses avantages et ses inconvénients, la manière de la prendre et ce qui peut modifier son efficacité; on explique quoi faire si on oublie de prendre la pilule, les effets secondaires possibles, de même que le…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Women's Choice Clinic
Alternate Title
Birth control pills
The pill
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
French
Physical Description
1 electronic document (10 p.) : digital, PDF file
Subjects (MeSH)
Ovulation Inhibition
Contraception - methods
Subjects (LCSH)
Oral contraceptives
Contraception
Abstract
La pilule contraceptive empêche la grossesse en arrêtant le cycle d’ovulation, en provoquant l’épaississement des sécrétions (mucus) du col de l’utérus et en modifiant la paroi intérieure de l’utérus. Le livret explique le fonctionnement de la pilule, le moment où elle commence son travail, ses avantages et ses inconvénients, la manière de la prendre et ce qui peut modifier son efficacité; on explique quoi faire si on oublie de prendre la pilule, les effets secondaires possibles, de même que les effets secondaires graves qu’il faut connaître. La pilule contraceptive n’est pas prescrite aux fumeuses de 35 ans et plus compte tenu des risques. La pilule ne vous protège pas contre les infections transmissibles sexuellement.
This is a French translation of the English pamphlet 0171, "Birth Control Pills". Birth control pills work to prevent pregnancy by stopping you from ovulating, thickening the mucus made by your cervix, and changing the lining of your uterus. This pamphlet explains how well the pill works, when it starts working, pros and cons, how to take it, what can change how well it works, instructions for missed pills, and possible side effects (as well as serious ones to be aware of). The pill is not prescribed to women over 35 who smoke due to the risks involved. The pill will not protect you against sexually transmitted infections (STIs).
Responsibility
Prepared by: Nova Scotia Women's Choice Clinic
Pamphlet Number
2027
Less detail

Pneumovax 23 (pneumococcal vaccine polyvalent) and kidney disease

https://libcat.nshealth.ca/en/permalink/chpams36445
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1890
Available Online
View Pamphlet
Pneumovax® 23 is a vaccine that protects against infections caused by the 23 most common types of Streptococcus pneumoniae bacteria. Infections commonly caused by Streptococcus pneumoniae include pneumonia (an infection in the lungs, also called a chest infection), meningitis (an infection of the lining around the brain), bacteremia (an infection of the blood and organs), sinusitis (a sinus infection), and otitis media (a middle ear infection). This pamphlet explains what Pneumovax® 23 is, what…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Pneumococcal Vaccines
Streptococcus pneumoniae
Kidney Diseases
Subjects (LCSH)
Pneumococcal vaccine
Streptococcus pneumoniae
Kidneys--Diseases
Specialty
Nephrology
Abstract
Pneumovax® 23 is a vaccine that protects against infections caused by the 23 most common types of Streptococcus pneumoniae bacteria. Infections commonly caused by Streptococcus pneumoniae include pneumonia (an infection in the lungs, also called a chest infection), meningitis (an infection of the lining around the brain), bacteremia (an infection of the blood and organs), sinusitis (a sinus infection), and otitis media (a middle ear infection). This pamphlet explains what Pneumovax® 23 is, what Streptococcus pneumoniae is, why you need to get vaccinated, the possible side effects of the vaccine, who should not get the vaccine, and when you should get it.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1890
Less detail

Polyoma virus and BK virus

https://libcat.nshealth.ca/en/permalink/chpams35425
Nova Scotia Health Authority. Kidney Transplant Clinic. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1510
Available Online
View Pamphlet
BK virus is a part of the polyoma virus family. About 80% of people carry the virus. People usually get this virus as children. It can stay inactive in your body without causing harm for many years. It can become active if you are immunocompromised (your immune system is weak). People who have had a kidney transplant and are taking immunosuppressive medications (medications that suppress [lower] your immune system) are at risk of infection from the virus. This pamphlet explains the symptoms of …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Kidney Transplant Clinic
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Polyomavirus
BK Virus
Kidney Transplantation - adverse effects
Immunosuppressive Agents - adverse effects
Subjects (LCSH)
Polyomaviruses
Kidneys--Transplantation
Immunosuppressive agents
Specialty
Nephrology
Medications
Abstract
BK virus is a part of the polyoma virus family. About 80% of people carry the virus. People usually get this virus as children. It can stay inactive in your body without causing harm for many years. It can become active if you are immunocompromised (your immune system is weak). People who have had a kidney transplant and are taking immunosuppressive medications (medications that suppress [lower] your immune system) are at risk of infection from the virus. This pamphlet explains the symptoms of BK virus, how BK virus is diagnosed, and how it is treated.
Responsibility
Prepared by: Kidney Transplant Clinic
Pamphlet Number
1510
Less detail

Pregnancy and Radiation Therapy

https://libcat.nshealth.ca/en/permalink/chpams37384
Nova Scotia Health. Cancer Care Program. [Halifax, NS]: Nova Scotia Health Authority Cancer Care Program , 2020.
Pamphlet Number
0070
Available Online
View Pamphlet
Radiation therapy can harm unborn babies. Information and next steps are provided for patients of childbearing age.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health. Cancer Care Program
Place of Publication
[Halifax, NS]
Publisher
Nova Scotia Health Authority Cancer Care Program
Date of Publication
2020
Format
Pamphlet
Language
English
Physical Description
1 electronic document : digital, PDF file
Subjects (MeSH)
Radiotherapy - adverse effects
Pregnancy complications
Pregnancy - radiation effects
Subjects (LCSH)
Cancer in pregnancy
Cancer--Radiotherapy--Complications
Cancer in women
Specialty
Radiotherapy
Abstract
Radiation therapy can harm unborn babies. Information and next steps are provided for patients of childbearing age.
Responsibility
prepared by Nova Scotia Health Authority Cancer Care Program ; approved by Nova Scotia Cancer Patient Education Committee
Pamphlet Number
0070
Less detail

Preparing for your lung screening chest CT scan

https://libcat.nshealth.ca/en/permalink/chpams38247
Nova Scotia Health. Cancer Care Program. Halifax, NS: Nova Scotia Health Cancer Care Program , 2024.
Pamphlet Number
4054
Available Online
View Pamphlet
A lung screening chest CT scan takes detailed pictures of the lungs. This pamphlet explains how to get ready for your scan, what will happen at the appointment, possible side effects, and what will happen after your appointment.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health. Cancer Care Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Cancer Care Program
Date of Publication
2024
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Neoplasms - prevention & control
Lung - diagnostic imaging
Lung Neoplasms - diagnosis
Subjects (LCSH)
Cancer
Lungs--Cancer--Diagnosis
Abstract
A lung screening chest CT scan takes detailed pictures of the lungs. This pamphlet explains how to get ready for your scan, what will happen at the appointment, possible side effects, and what will happen after your appointment.
Responsibility
Prepared by: Nova Scotia Health Cancer Care Program
Pamphlet Number
4054
Less detail

Prevnar 13 (pneumococcal conjugate vaccine) and kidney disease

https://libcat.nshealth.ca/en/permalink/chpams36443
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1889
Available Online
View Pamphlet
Prevnar® 13 is a vaccine that protects against infections caused by the 13 most common types of Streptococcus pneumoniae bacteria. Infections commonly caused by Streptococcus pneumoniae include pneumonia (an infection in the lungs, also called a chest infection), meningitis (an infection of the lining around the brain), bacteremia (an infection of the blood and organs), sinusitis (a sinus infection), and otitis media (a middle ear infection). This pamphlet explains what Prevnar® 13 is, what Str…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Heptavalent Pneumococcal Conjugate Vaccine
Streptococcus pneumoniae
Kidney Diseases
Subjects (LCSH)
Streptococcus pneumoniae
Kidneys--Diseases
Specialty
Nephrology
Abstract
Prevnar® 13 is a vaccine that protects against infections caused by the 13 most common types of Streptococcus pneumoniae bacteria. Infections commonly caused by Streptococcus pneumoniae include pneumonia (an infection in the lungs, also called a chest infection), meningitis (an infection of the lining around the brain), bacteremia (an infection of the blood and organs), sinusitis (a sinus infection), and otitis media (a middle ear infection). This pamphlet explains what Prevnar® 13 is, what Streptococcus pneumoniae is, why you need to get vaccinated, the possible side effects of the vaccine, who should not get the vaccine, and when you should get it.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1889
Less detail

Prostate High Dose Rate (HDR) Brachytherapy Post-treatment Instructions

https://libcat.nshealth.ca/en/permalink/chpams37413
Nova Scotia Health. Cancer Care Program. [Halifax, NS]: Nova Scotia Cancer Care Program , 2018.
Pamphlet Number
1490
Available Online
View Pamphlet
This pamphlet describes the recovery process after High Dose-Rate (HDR) Brachytherapy treatment for prostate cancer. It outlines what to expect, possible side effects, and details for contacting your health care team with any questions or concerns.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health. Cancer Care Program
Place of Publication
[Halifax, NS]
Publisher
Nova Scotia Cancer Care Program
Date of Publication
2018
Format
Pamphlet
Language
English
Physical Description
1 electronic document (4 p.) : digital, PDF file
Subjects (MeSH)
Aftercare
Brachytherapy
Prostatic Neoplasms - radiotherapy
Subjects (LCSH)
Prostate--Cancer--Radiotherapy
Radioisotope brachytherapy
Self-care, Health
Specialty
Aftercare
Radiotherapy
Men's Health
Abstract
This pamphlet describes the recovery process after High Dose-Rate (HDR) Brachytherapy treatment for prostate cancer. It outlines what to expect, possible side effects, and details for contacting your health care team with any questions or concerns.
Notes
Patient & family guide
Responsibility
prepared by Nova Scotia Cancer Care Program
Pamphlet Number
1490
Less detail

Radiation therapy

https://libcat.nshealth.ca/en/permalink/chpams37346
Nova Scotia Health. Cancer Care Program. [Halifax, NS]: Nova Scotia Cancer Care Program , 2024.
Pamphlet Number
4067
Available Online
View Pamphlet
This pamphlet describes how radiation therapy works, why it has been recommended for you, and the different types of radiation treatment. Other information like how to get ready for each treatment, how long and how often the treatment will take place, and how to manage side effects, is also listed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health. Cancer Care Program
Place of Publication
[Halifax, NS]
Publisher
Nova Scotia Cancer Care Program
Date of Publication
2024
Format
Pamphlet
Language
English
Physical Description
1 electronic document (4 p.) : digital, PDF file
Subjects (MeSH)
Neoplasms - radiotherapy
Radiotherapy
Subjects (LCSH)
Cancer--Radiotherapy
Radiotherapy
Specialty
Radiotherapy
Abstract
This pamphlet describes how radiation therapy works, why it has been recommended for you, and the different types of radiation treatment. Other information like how to get ready for each treatment, how long and how often the treatment will take place, and how to manage side effects, is also listed.
Responsibility
Prepared by: Nova Scotia Health Cancer Care Program
Pamphlet Number
4067
Less detail

Radiation therapy : what to expect when treatments are finished

https://libcat.nshealth.ca/en/permalink/chpams37393
Nova Scotia Health. Cancer Care Program. [Halifax, NS]: Nova Scotia Health Cancer Care Program , 2024.
Pamphlet Number
4066
Available Online
View Pamphlet
This pamphlet explains what to expect when you come to the end of your radiation treatments. Topics include when your side effects will go away, how you should expect to feel over the coming weeks, and if you will need to make changes to your lifestyle. Questions you may want to ask your Health Care Team are included.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health. Cancer Care Program
Place of Publication
[Halifax, NS]
Publisher
Nova Scotia Health Cancer Care Program
Date of Publication
2024
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Aftercare
Neoplasms - radiotherapy
Self Care
Subjects (LCSH)
Cancer--Patients
Cancer--Radiotherapy
Self-care, Health
Abstract
This pamphlet explains what to expect when you come to the end of your radiation treatments. Topics include when your side effects will go away, how you should expect to feel over the coming weeks, and if you will need to make changes to your lifestyle. Questions you may want to ask your Health Care Team are included.
Notes
Previous title: Radiation therapy : what to expect once the treatments are finished
Responsibility
Prepared by: Nova Scotia Health Cancer Care Program
Pamphlet Number
4066
Less detail

Repetitive Transcranial Magnetic Stimulation (rTMS)

https://libcat.nshealth.ca/en/permalink/chpams36546
Nova Scotia Health Authority. NSH. rTMS Department. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1975
Available Online
View Pamphlet
Repetitive Transcranial Magnetic Stimulation (rTMS) is a type of brain stimulation therapy used to treat symptoms of depression. This pamphlet explains how rTMS works, as well as the possible side effects. Information about treatments includes where to go, how to get ready, and what will happen during the treatment. Contact information and a list of symptoms needing medical attention are also provided.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. NSH. rTMS Department
Alternate Title
Repetitive TMS
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Transcranial Magnetic Stimulation
Depression - therapy
Subjects (LCSH)
Magnetic brain stimulation
Depression, Mental
Abstract
Repetitive Transcranial Magnetic Stimulation (rTMS) is a type of brain stimulation therapy used to treat symptoms of depression. This pamphlet explains how rTMS works, as well as the possible side effects. Information about treatments includes where to go, how to get ready, and what will happen during the treatment. Contact information and a list of symptoms needing medical attention are also provided.
Responsibility
Prepared by: rTMS Department, Nova Scotia Hospital
Pamphlet Number
1975
Less detail

Repetitive transcranial magnetic stimulation (rTMS) : Colchester East Hants Health Centre

https://libcat.nshealth.ca/en/permalink/chpams38291
Nova Scotia Health Authority. Colchester East Hants Health Centre. Neuromodulation Clinic. Halifax, NS: Nova Scotia Health Authority , 2024.
Pamphlet Number
2412
Available Online
View Pamphlet
Repetitive Transcranial Magnetic Stimulation (rTMS) is a type of brain stimulation therapy used to treat symptoms of depression. This pamphlet explains how rTMS works, as well as the possible side effects. Information about treatments includes where to go, how to get ready, and what will happen during the treatment.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Colchester East Hants Health Centre. Neuromodulation Clinic
Alternate Title
Repetitive TMS : CEHHC
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2024
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Transcranial Magnetic Stimulation
Depression - therapy
Subjects (LCSH)
Magnetic brain stimulation
Depression, Mental
Specialty
Mental Health and Addictions
Abstract
Repetitive Transcranial Magnetic Stimulation (rTMS) is a type of brain stimulation therapy used to treat symptoms of depression. This pamphlet explains how rTMS works, as well as the possible side effects. Information about treatments includes where to go, how to get ready, and what will happen during the treatment.
Responsibility
Prepared by: Neuromodulation Clinic, CEHHC
Pamphlet Number
2412
Less detail

Repetitive Transcranial Magnetic Stimulation (rTMS) - Valley Regional Hospital

https://libcat.nshealth.ca/en/permalink/chpams37578
Nova Scotia Health Authority. Valley Regional Hospital. Neuromodulation Services. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
2280
Available Online
View Pamphlet
Repetitive Transcranial Magnetic Stimulation (rTMS) is a type of brain stimulation therapy used to treat symptoms of depression. rTMS is often used for patients who have not had good results with medication. This pamphlet explains how rTMS works, as well as the possible side effects. Information about treatments includes where to go, how to get ready, and what will happen during the treatment. Contact information and a list of symptoms needing medical attention are also provided.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Valley Regional Hospital. Neuromodulation Services
Alternate Title
Repetitive TMS
rTMS
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Transcranial Magnetic Stimulation
Depression - therapy
Subjects (LCSH)
Magnetic brain stimulation
Depression, Mental
Abstract
Repetitive Transcranial Magnetic Stimulation (rTMS) is a type of brain stimulation therapy used to treat symptoms of depression. rTMS is often used for patients who have not had good results with medication. This pamphlet explains how rTMS works, as well as the possible side effects. Information about treatments includes where to go, how to get ready, and what will happen during the treatment. Contact information and a list of symptoms needing medical attention are also provided.
Responsibility
Prepared by: Neuromodulation Services, Valley Regional Hospital
Pamphlet Number
2280
Less detail

Risankizumab (Skyrizi®) therapy for inflammatory bowel disease (IBD)

https://libcat.nshealth.ca/en/permalink/chpams38191
Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
2345
Available Online
View Pamphlet
Risankizumab is a biologic medication. A biologic medication is a type of medication that treats inflammation. This pamphlet explains how risankizumab works, how it is given, and how long you can expect to take it. Precautions, side effects, and what to expect after treatment are explained. Side effects that require contacting your primary health care provider are listed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document (9 p.) : digital, PDF file
Subjects (MeSH)
Inflammatory Bowel Diseases - drug therapy
Subjects (LCSH)
Inflammatory bowel diseases
Specialty
Gastrointestinal System
Medications
Abstract
Risankizumab is a biologic medication. A biologic medication is a type of medication that treats inflammation. This pamphlet explains how risankizumab works, how it is given, and how long you can expect to take it. Precautions, side effects, and what to expect after treatment are explained. Side effects that require contacting your primary health care provider are listed.
Responsibility
Prepared by: Nova Scotia Collaborative IBD Program
Pamphlet Number
2345
Less detail

Risperidone (Risperdal, Risperdal Consta)

https://libcat.nshealth.ca/en/permalink/chpams35648
Nova Scotia Health Authority. Pharmacy Services. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1639
Available Online
View Pamphlet
Risperidone is most often used to treat psychosis or mania. It is also used to treat some symptoms of dementia. This pamphlet explains how to take risperidone, how it helps, how quickly it will work, how long you should take it, and possible side effects. A list of symptoms that need medical attention is included.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Pharmacy Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Risperidone
Subjects (LCSH)
Antipsychotic drugs
Specialty
Medications
Abstract
Risperidone is most often used to treat psychosis or mania. It is also used to treat some symptoms of dementia. This pamphlet explains how to take risperidone, how it helps, how quickly it will work, how long you should take it, and possible side effects. A list of symptoms that need medical attention is included.
Responsibility
Prepared by: Pharmacy Services
Pamphlet Number
1639
Less detail

Rocaltrol® (calcitriol) and hemodialysis

https://libcat.nshealth.ca/en/permalink/chpams36671
Nova Scotia Health Authority. Pharmacy Services, Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1468
Available Online
View Pamphlet
Rocaltrol® is a medication with the active ingredient calcitriol. This is a form of vitamin D that can be used by the body. Calcitriol helps your body control your calcium and phosphate levels. Calcium and phosphate are needed to build healthy bones. People get vitamin D from sunlight, and from eating oily fish and milk products. People with kidney disease cannot change enough vitamin D into calcitriol. This can cause low calcium levels in the blood and weaker bones. Rocaltrol raises the amoun…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Pharmacy Services
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal Insufficiency, Chronic - drug therapy
Renal Dialysis
Calcitriol
Subjects (LCSH)
Chronic renal failure
Kidneys--Diseases--Treatment
Hemodialysis
Abstract
Rocaltrol® is a medication with the active ingredient calcitriol. This is a form of vitamin D that can be used by the body. Calcitriol helps your body control your calcium and phosphate levels. Calcium and phosphate are needed to build healthy bones. People get vitamin D from sunlight, and from eating oily fish and milk products. People with kidney disease cannot change enough vitamin D into calcitriol. This can cause low calcium levels in the blood and weaker bones. Rocaltrol raises the amount of vitamin D in your body that can be used. How to take the medication, side effects to watch for, and how to store it are reviewed. Rocaltrol® is a brand name for calcitriol.
Responsibility
Prepared by: Renal Pharmacy Team, Renal Program
Pamphlet Number
1468
Less detail

Sclerotherapy discharge instructions - Dr. MacKean

https://libcat.nshealth.ca/en/permalink/chpams35640
Nova Scotia Health Authority. QEII. Minor Procedures. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
0206
Available Online
View Pamphlet
Your varicose veins have been injected with a special medication during a treatment called sclerotherapy. This medication causes a blockage in your varicose veins. This forces the blood to go around the blockage and travel through nearby healthier veins, increasing blood flow in your legs. This pamphlet gives specific directions to prevent blood clots from forming in your healthy veins. Mild side effects and a list of symptoms that require immediate medical attention are provided.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Minor Procedures
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Sclerotherapy
Subjects (LCSH)
Sclerotherapy
Specialty
Cardiovascular System
Abstract
Your varicose veins have been injected with a special medication during a treatment called sclerotherapy. This medication causes a blockage in your varicose veins. This forces the blood to go around the blockage and travel through nearby healthier veins, increasing blood flow in your legs. This pamphlet gives specific directions to prevent blood clots from forming in your healthy veins. Mild side effects and a list of symptoms that require immediate medical attention are provided.
Responsibility
Prepared by: Minor Procedures & G. MacKean MD, QEII, Halifax
Pamphlet Number
0206
Less detail

145 records – page 6 of 8.